We’ve just wrapped up our most successful ever NATF Thrombosis Summit at the Fairmont Copley Plaza Hotel in Boston. I’ve received dozens of emails praising the event, and many physicians and patients have told me in person how much they enjoyed and learned from the lectures, discussion, and Q&A. Topics spanned the 3 major cardiovascular thrombotic diseases: myocardial infarction, stroke, and pulmonary embolism.
Click here to read the full letter.
My experience with DVT/PE
"Being a Senator, I used to travel a lot, both within and outside the U.S. I was always in good health, my husband being a cardiologist. In 2001, I travelled with my family to San Diego, California, for a legislative convention. One afternoon, I was walking up a flight of stairs in a pair of flat sandals when I suddenly tripped on the edge of a step and immediately felt acute pain in my leg..."
My family experience with DVT/PE
"What is our story? I had a PE 15 years ago and a DVT a year later. The first question I am always asked is what were the symptoms. For the PE, I had no symptoms until I had shortness of breath and a rapid pulse for no apparent reason ... We did think it was genetic, because my father’s mother had died abruptly after surgery. When my mother had a PE at 98, I found it was on both sides of my family..."
Deep vein thrombosis: a silent danger
NATF member Atul Laddu, MD, PhD, FACC raises DVT awareness with an article published in the September/October issue of Healthy Living Made Simple. Dr. Laddu writes, "A current study from the American Heart Association estimates the total econmic burden of illness associated with DVT and PE to reach between $5-8 billion annually--an average of $20,000 per treated patient per year. The good news? These conditions are entirely preventable."
Raising thrombosis awareness for young people
Young people are not immune to thrombosis. In this video, Dr. Piazza discusses why young people can be at risk of getting a DVT or PE, and how raising awareness can increase the liklihood of prevention.
iQ&A Cardiovascular Intelligence Zone: Comprehensive Thrombosis Care
How do you know if it's a pulmonary embolism?
Everyday Health: 15 October 2014 - Pulmonary embolism survival rate is excellent only if detected early and treated quickly.
You might think that something potentially fatal would be easy to detect. But with a pulmonary embolism, a blood clot in your lungs that blocks one or more arteries, that's not necessarily the case.
Novel oral anticoagulants vs. warfarin: The debate continues
Healio: 24 October 2014 - The burden of stroke related to atrial fibrillation is substantial and there is ongoing debate about the best therapy for stroke prevention in patients with nonvalvular atrial fibrillation: warfarin or a novel oral anticoagulant.
During a debate session at the Cardiometabolic Health Congress, Robert A. Harrington, MD, and Ph. Gabriel Steg, MD, discussed the efficacy profile, cost and ease-of-use issues associated with the novel oral anticoagulants as compared with warfarin in this patient population.
Deep Vein Thrombosis Treated with Advanced Screening, Procedures at NY Heart Health Clinics
PR Newswire: 11 September 2014 - "Many Americans have heard that heart disease and stroke are the two leading cardiovascular diseases in the US but most don't realize that deep vein thrombosis, or DVT and resulting pulmonary embolisms rank number three.